nadifloxacin has been researched along with Infections, Staphylococcal in 3 studies
nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Souza, NJ | 2 |
| Gupte, SV | 2 |
| Deshpande, PK | 1 |
| Desai, VN | 1 |
| Bhawsar, SB | 1 |
| Yeole, RD | 1 |
| Shukla, MC | 1 |
| Strahilevitz, J | 1 |
| Hooper, DC | 1 |
| Bozdogan, B | 1 |
| Appelbaum, PC | 2 |
| Jacobs, MR | 2 |
| Shetty, N | 1 |
| Patel, MV | 2 |
| Jha, R | 1 |
| Khorakiwala, HF | 2 |
| Jafri, MA | 1 |
| Bhagwat, SS | 1 |
| Chugh, Y | 1 |
| Kimata, H | 1 |
1 trial available for nadifloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
Effect of nadifloxacin on atopic dermatitis with methicillin-resistant Staphylococcus aureus in young children.
Topics: Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Bufexamac; Dermatitis, Ato | 1999 |
2 other studies available for nadifloxacin and Infections, Staphylococcal
| Article | Year |
|---|---|
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resi | 2005 |
Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; Cellulit | 2004 |